ATE429905T1 - PHARMACEUTICAL COMPOSITION CONTAINING OXCARBAZEPINE WITH CONTROLLED RELEASE - Google Patents

PHARMACEUTICAL COMPOSITION CONTAINING OXCARBAZEPINE WITH CONTROLLED RELEASE

Info

Publication number
ATE429905T1
ATE429905T1 AT03730048T AT03730048T ATE429905T1 AT E429905 T1 ATE429905 T1 AT E429905T1 AT 03730048 T AT03730048 T AT 03730048T AT 03730048 T AT03730048 T AT 03730048T AT E429905 T1 ATE429905 T1 AT E429905T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
composition containing
controlled release
containing oxcarbazepine
oxcarbazepine
Prior art date
Application number
AT03730048T
Other languages
German (de)
Inventor
Hanshermann Franke
Peter Lennartz
Original Assignee
Desitin Arzneimittel Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10224170A external-priority patent/DE10224170A1/en
Priority claimed from DE10250566A external-priority patent/DE10250566A1/en
Application filed by Desitin Arzneimittel Gmbh filed Critical Desitin Arzneimittel Gmbh
Priority claimed from PCT/EP2003/005116 external-priority patent/WO2003101430A1/en
Application granted granted Critical
Publication of ATE429905T1 publication Critical patent/ATE429905T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to the pharmaceutical compositions, especially for oral administration, containing therapeutically efficient quantity of oxcarbazepin with prolonged release of the active ingredient in vitro.
AT03730048T 2002-05-31 2003-05-15 PHARMACEUTICAL COMPOSITION CONTAINING OXCARBAZEPINE WITH CONTROLLED RELEASE ATE429905T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10224177 2002-05-31
DE10224170A DE10224170A1 (en) 2002-05-31 2002-05-31 Retarded release pharmaceutical composition, obtained without use of organic solvents or water by densifying mixture of active agent and retarding polymer in heated rollers
DE10250566A DE10250566A1 (en) 2002-05-31 2002-10-30 Pharmaceutical composition containing oxcarbazepine, having suitable release profile for once-daily administration in treatment of epilepsy, pain or alcohol withdrawal symptoms
PCT/EP2003/005116 WO2003101430A1 (en) 2002-05-31 2003-05-15 Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release

Publications (1)

Publication Number Publication Date
ATE429905T1 true ATE429905T1 (en) 2009-05-15

Family

ID=40600478

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03730048T ATE429905T1 (en) 2002-05-31 2003-05-15 PHARMACEUTICAL COMPOSITION CONTAINING OXCARBAZEPINE WITH CONTROLLED RELEASE

Country Status (4)

Country Link
KR (1) KR20050010843A (en)
AT (1) ATE429905T1 (en)
DE (1) DE50311479D1 (en)
MD (1) MD20040296A (en)

Also Published As

Publication number Publication date
DE50311479D1 (en) 2009-06-10
MD20040296A (en) 2005-05-31
KR20050010843A (en) 2005-01-28

Similar Documents

Publication Publication Date Title
BG66093B1 (en) Controlled release compositions comprising nimesulide
EE200300033A (en) Cyclopentanoindoles, their use in the preparation of a medicament, and the pharmaceutical composition containing them
ATE302616T1 (en) MEDICINAL COMPOSITIONS FOR ORAL APPLICATION WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS
PL370292A1 (en) Formulations for oral administration of active compounds
BR0015188A (en) Pharmaceutical compositions
CY1111470T1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLYVERSERIN POLYMORPH A
MXPA03007857A (en) Compounds and compositions for delivering active agents.
EA200901393A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING GESTAGENES AND / OR ESTROGENS AND 5 METHYL- (6S) -TETRAHYDROPHOLATE
ATE252377T1 (en) CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING TILIDINE MESYLATE AS THE ACTIVE INGREDIENT
PL1750862T3 (en) Pharmaceutical composition containing irbesartan
DE69923336D1 (en) ORANGE BUPRENORPHINIC MEDICINAL PRODUCTS TO BE APPLIED
AP2003002763A0 (en) Controlled release formulations for oral administration
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
DE60205905D1 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION WITH IMPROVED BIOAVAILABILITY
DE602004016963D1 (en) Therapeutisches system mit amoxicillin und clavulansäure
NO20064808L (en) Oral matrix formulations with licarbazepine
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
EA200601015A1 (en) ORAL COMPOSITIONS OF DEOXYPEGANINE AND THEIR APPLICATION
ATE460934T1 (en) PHARMACEUTICAL PREPARATIONS OF CIPROFLOXACIN
ATE357220T1 (en) MODIFIED RELEASE PHARMACEUTICAL COMPOSITION
DE50311479D1 (en) PHARMACEUTICAL COMPOSITION, CONTAINING OXCARBAZEPINE WITH CONTROLLED ACTIVE INGREDIENTS
SE0203817D0 (en) New composition
WO2001095890A3 (en) Oral pharmaceutical compositions containing terbinafine
TNSN06299A1 (en) Oral matrix formulations comprising licarbazepine
MY145885A (en) Controlled release formulations for oral administration

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee